Results 1 to 10 of about 1,880,763 (299)

Advances and prospects in tumor infiltrating lymphocyte therapy [PDF]

open access: yesDiscover Oncology
Tumor-infiltrating lymphocyte (TIL) therapy in adoptive T-cell therapy (ACT) has already caused durable regression in a variety of cancer types due to T-cell persistence, clinical activity, and duration of objective response and safety. TILs are composed
Xu Qiu   +7 more
doaj   +3 more sources

Characteristics of lymphocyte-infiltrating papillary thyroid cancer

open access: yesJournal of Cancer Research and Practice, 2017
Background: The tumor-promoting or tumor-suppressing role of tumor-associated lymphocytes remains a subject of debate. We examined thyroid cancer data from The Cancer Genome Atlas in an attempt to define the relationship between lymphocyte infiltrates ...
Chi-Yu Kuo   +3 more
doaj   +2 more sources

The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells [PDF]

open access: yesCommunications Biology, 2021
Ito et al. generated and characterized multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells (TIL-iPSC) using human colorectal cancer specimens.
Takeshi Ito   +11 more
doaj   +2 more sources

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2023
Background Tumor-infiltrating neutrophils and lymphocytes play essential roles in promoting or combating various neoplasms. This study aimed to investigate the association between tumor-infiltrating neutrophils and lymphocytes and the neutrophil-to ...
Wael Abdo Hassan   +5 more
doaj   +2 more sources

Tumor-infiltrating lymphocyte immunotherapy comes of age: a journey of development in the Surgery Branch, NCI [PDF]

open access: yesJournal for ImmunoTherapy of Cancer
The early development of tumor-infiltrating lymphocytes into an effective clinical strategy was fundamentally the work of hundreds of scientists and clinicians within the Surgery Branch of the National Cancer Institute under the leadership of Steven ...
Steven A Rosenberg, Stephanie L Goff
doaj   +2 more sources

Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer [PDF]

open access: yesFrontiers in Immunology
Cervical cancer is a common malignant tumor in women, and human papillomavirus (HPV) infection is a major cause of cervical cancer. Tumor-infiltrating lymphocytes (TILs) are a heterogeneous group of lymphocytes primarily composed of T lymphocytes found ...
Wei Zhang   +9 more
doaj   +2 more sources

Tumor‐infiltrating lymphocyte therapy and the mucosal melanoma treatment landscape [PDF]

open access: yesCancer Communications
Jennifer Thomas   +3 more
doaj   +2 more sources

Evaluation of tumor infiltrating lymphocytes in breast carcinomas

open access: yesJournal of Pathology of Nepal, 2022
Background: Among the parameters that have a prognostic and/or predictive significance to therapeutic response, in the case of breast carcinoma, the study of tumor-infiltrating lymphocytes in breast carcinomas is emerging.
Shovana Karki   +2 more
doaj   +1 more source

CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms’ tumor

open access: yesTumor Biology, 2020
The abundance and location of CD8+ tumor-infiltrating lymphocytes demonstrate important facets of the anticancer immune response. CD8-expressing lymphocytes have been used in immunotherapy for multiple cancers.
Keykhosro Mardanpour   +4 more
doaj   +1 more source

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2022
Introduction: Many studies have focused on the role of programmed death receptor ligand 1 (PD-L1) expression in predicting immunotherapy outcomes. Limited clinical data are available regarding the role of programmed death receptor 1 (PD-1; the PD-L1 ...
Nicholas J. Bevins   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy